The treatment of diabetic dyslipidemia
Rubinstein, A.; Izhakov, E.
Harefuah 140(8): 744-746
2001
ISSN/ISBN: 0017-7768 PMID: 11547480 Document Number: 539562
Document emailed within 1 workday
Related Documents
Bertone, V.; Locatelli, A.; De Francesco, F.; Colloredo, G.; Angeli, G. 1985: Epidemiologic study of diabetic dyslipidemia Minerva Dietologica E Gastroenterologica 31(1): 7-14Hussain, M.; Shad, M.N.; Akhtar, L. 2017: Pioglitazone attenuates cardiometabolic risk factors in non-diabetic patients with dyslipidemia JPMA. Journal of the Pakistan Medical Association 67(12): 1884-1888
Pratipanawatr, T.; Rawdaree, P.; Chetthakul, T.; Bunnag, P.; Ngarmukos, C.; Benjasuratwong, Y.; Leelawatana, R.; Kosachunhanun, N.; Plengvidhya, N.; Deerochanawong, C.; Suwanwalaikorn, S.; Krittiyawong, S.; Mongkolsomlit, S.; Komoltri, C. 2006: Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients Journal of the Medical Association of Thailand 89(Suppl 1): S60-S65
Ashida, T. 2001: Treatment of hypertension with dyslipidemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(5): 978-982
Jędras, Mław.; Dylewska, M. 2014: Current guidelines for treatment of dyslipidemia in kidney diseases Wiadomosci Lekarskie 67(3): 426-428
Davignon, J. 1998: Advances in drug treatment of dyslipidemia: focus on atorvastatin Canadian Journal of Cardiology 14(Suppl): 28b-38b
Shilov, A.M.; Sviatov, I.S.; Chubarov, M.V.; Sanodze, I.D. 1998: Treatment and prevention of hyper- and dyslipidemia with magnesium-containing drugs Klinicheskaia Meditsina 76(4): 35-37
Vigna, G.Battista.; Fellin, R. 2003: Dyslipidemia and global cardiovascular risk: treatment guidelines Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4 Suppl. 7: 4s
Bergesio, F.; Ciuti, R.; Innocenti, D.; Galli, G.A.; Frizzi, V. 1985: Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment Giornale di Clinica Medica 66(11-12): 433-440
Aronov, D.M. 1996: The role of nicotinic acid in the treatment of atherosclerosis and atherogenic dyslipidemia Klinicheskaia Meditsina 74(9): 48-52
Salgado, B.J.; Salgado, J.V.; Dos Santos, A.M.; Casulari, L.A. 2010: Effects of low-dose of niacin associated to simvastatin in the treatment of mixed dyslipidemia Salgad Minerva Cardioangiologica 58(5): 531-542
Downey, P.; Maiz, A.; Vaccarezza, A.; Pinto, C.; Retamal, F.; Martínez, L. 1995: Renal transplantation and dyslipidemia: characterization of a population and treatment with diet and low dose lovastatin Transplantation Proceedings 27(2): 1803-1805
Aparicio, M. 2000: Treatment of the dyslipidemia of chronic renal insufficiency: respective place of statins and diet Nephrologie 21(7): 381-382
Kahya Eren, N.; Harman, E.; Dolek, D.; Emren, S.; Tütüncüoğlu, A.P.; Nazli, C.; Ergene, O. 2014: The gap between the current dyslipidemia guidelines and the physicians' treatment targets in patients with type 2 diabetes in Turkey Minerva Cardioangiologica 62(3): 287-295
Kadowaki, T. 2010: Diabetic treatment strategies to control the onset and development of diabetic macrovascular disease Nihon Rinsho. Japanese Journal of Clinical Medicine 68(5): 788-795
Rusavý, Z.; Cechurová, D.; Holubec, L.; Lacigová, S.; Jankovec, Z.; Treska, V. 2002: Treatment of diabetic neuropathic defect at the surgery department and at the center for diabetic foot care Vnitrni Lekarstvi 48(4): 285-289
Nouedoui, C.; Teyang, A.; Djoumessi, Sène. 2003: Epidemiologic profile and treatment of diabetic foot at the National Diabetic Center of Yaounde-Cameroon La Tunisie Medicale 81(1): 20-25
Nouedoui, C.; Teyang, A.; Djoumessi, Sène. 2003: Epidemiologic profile and treatment of diabetic foot at the National Diabetic Center of Yaounde-Cameroon La Tunisie Medicale 81(1): 20-25
Laghate, V.D.; Gupta, S.B. 2004: Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol Journal of the Association of Physicians of India 52: 257-258
Suzuki, H.; Inoue, T.; Watanabe, Y.; Kikuta, T.; Sato, T.; Tsuda, M. 2010: Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 26: 53-57